|
1
|
Ferrannini E, Balkau B, Coppack SW, et al;
RISC Investigators. Insulin resistance, insulin response, and
obesity as indicators of metabolic risk. J Clin Endocrinol Metab.
92:2885–2892. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haffner SM, D’Agostino R Jr, Mykkänen L,
et al: Insulin sensitivity in subjects with type 2 diabetes.
Relationship to cardiovascular risk factors: the Insulin Resistance
Atherosclerosis Study. Diabetes Care. 22:562–568. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tanti JF, Ceppo F, Jager J and Berthou F:
Implication of inflammatory signaling pathways in obesity-induced
insulin resistance. Front Endocrinol (Lausanne).
3:1812013.PubMed/NCBI
|
|
4
|
Fresno M, Alvarez R and Cuesta N:
Toll-like receptors, inflammation, metabolism and obesity. Arch
Physiol Biochem. 117:151–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zoico E, Di Francesco V, Olioso D, et al:
In vitro aging of 3T3-L1 mouse adipocytes leads to altered
metabolism and response to inflammation. Biogerontology.
11:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weng XG, Bai LW, Liu HZ, Wang T and Chen
LL: Effects of Astragalus polysaccharides on expression of
adiponectin in 3T3-L1 adipocytes. J Appl Clin Pediatr.
24:1598–1600. 2009.(In Chinese).
|
|
7
|
Zhao M, Zhang ZF, Ding Y, Wang JB and Li
Y: Astragalus polysaccharide improves palmitate-induced insulin
resistance by inhibiting PTP1B and NF-κB in C2C12 myotubes.
Molecules. 17:7083–7092. 2012.PubMed/NCBI
|
|
8
|
Zhang JB: Medical Cell Biology experiments
guidance and Exercises. Beijing: People’s Medical Publishing House;
2005, pp. 107
|
|
9
|
Ramírez-Zacarías JL1, Castro-Muñozledo F
and Kuri-Harcuch W: Quantitation of adipose conversion and
triglycerides by staining intracytoplasmic lipids with Oil red O.
Histochemistry. 97:493–497. 1992.PubMed/NCBI
|
|
10
|
Cheal KL, Abbasi F, Lamendola C,
McLaughlin T, Reaven GM and Ford ES: Relationship to insulin
resistance of the adult treatment panel III diagnostic criteria for
identification of the metabolic syndrome. Diabetes. 53:1195–1200.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao XM: Traditional Chinese Pharmacology.
Beijing: Traditional Chinese Medicine Publishing House; 2011, pp.
428
|
|
12
|
Wu M and Tan R: Advance in study on
astragalus polysaccharide. Journal of North Sichuan Medical
College. 28:17–22. 2013.(In Chinese).
|
|
13
|
Cui J, Panse S and Falkner B: The role of
adiponectin in metabolic and vascular disease: a review. Clin
Nephrol. 75:26–33. 2011.PubMed/NCBI
|
|
14
|
Phillips SA and Kung JT: Mechanisms of
adiponectin regulation and use as a pharmacological target. Curr
Opin Pharmacol. 10:676–683. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lavrenko AV, Shlykova OA, Kutsenko LA,
Mamontova TV and Kaĭdashev IP: Pharmacogenetic features of the
effect of metformin in patients with coronary heart disease in the
presence of metabolic syndrome and type 2 diabetes mellitus in
terms of PPAR-gamma2 gene polymorphism. Ter Arkh. 84:35–40.
2012.(In Russian).
|
|
16
|
Lefils-Lacourtablaise J, Socorro M, Géloën
A, et al: The eicosapentaenoic acid metabolite
15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion
by adipocytes partly via a PPARγ-dependent mechanism. PLoS One.
8:e639972013.PubMed/NCBI
|
|
17
|
Kubota N, Terauchi Y, Kubota T, et al:
Pioglitazone ameliorates insulin resistance and diabetes by both
adiponectin-dependent and -independent pathways. J Biol Chem.
281:8748–8755. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tishinsky JM, Ma DW and Robinson LE:
Eicosapentaenoic acid and rosiglitazone increase adiponectin in an
additive and PPARγ-dependent manner in human adipocytes. Obesity
(Silver Spring). 19:262–268. 2011.PubMed/NCBI
|
|
19
|
Bak EJ, Park HG, Kim JM, Kim JM, Yoo YJ
and Cha JH: Inhibitory effect of evodiamine alone and in
combination with rosiglitazone on in vitro adipocyte
differentiation and in vivo obesity related to diabetes. Int J Obes
(Lond). 34:250–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu M, Ouyang JP, Wu K, et al: Effect of
Astragalus polysaccharide on Ser phosphorylation of protein kinase
B in skeletal muscle of KKAy mice. Medical Journal of Wuhan
University. 27:135–139. 2006.(In Chinese).
|
|
21
|
Gao P, Li Q, Sun YZ and Zhang JC:
Continuously activated Akt inhibits adiponectin secretion in 3T3-L1
adipocytes. Chinese Journal of Diabetes. 14:142–143. 1452006.(In
Chinese).
|
|
22
|
Goldberg RB: Cytokine and cytokine-like
inflammation markers, endothelial dysfunction, and imbalanced
coagulation in development of diabetes and its complications. J
Clin Endocrinol Metab. 94:3171–3182. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Phillips CM and Perry IJ: Does
inflammation determine metabolic health status in obese and
nonobese adults? J Clin Endocrinol Metab. 98:E1610–E1619. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei SS and Liang DD: The effect of
exercises on TNF-alpha, IL-6 and adiponectin in different fat diet
rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 29:280–282. 2013.(In
Chinese).
|
|
25
|
Conroy SM, Chai W, Lim U, Franke AA,
Cooney RV and Maskarinec G: Leptin, adiponectin, and obesity among
Caucasian and Asian women. Mediators Inflamm. 2011:2535802011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rotter V, Nagaev I and Smith U:
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1
adipocytes and is, like IL-8 and tumor necrosis factor-alpha,
overexpressed in human fat cells from insulin-resistant subjects. J
Biol Chem. 278:45777–45784. 2003. View Article : Google Scholar
|
|
27
|
Liu HF, Ren YH, Han ZX, et al: Effect of
astragalus polysaccharides on insulin resistance and gene
expression of GLUT4 in type 2 diabetes mellitus rats. Chinese
Journal of Gerontology. 31:3988–3989. 2011.(In Chinese).
|
|
28
|
Xu Y, Wang BH, LI K, et al:
Insulin-sensitization of Astragalus polysaccharide and its effect
on protein tyrosine phosphatase 1B. Medical Journal of Wuhan
University. 3:288–291. 2010.(In Chinese).
|
|
29
|
Hu YQ, Li J, Liu J, Ou-Yang JP and Song J:
APS improves free fatty acid metabolism by activating AMPK and
promoting translocation of FAT/CD36 in C2C12 myoblasts. Chin J
Pathophysiol. 29:637–640. 2013.(In Chinese).
|
|
30
|
Liang LJ, Wang HX, Sun XF, et al:
Astragalus polysaccharides ameliorate hypertrophy of
cardiomyocytes induced by tumor necrosis factor-α via TLR4/NF-κB
signaling pathway. Chin J Pharmacol Toxicol. 27:168–173. 2013.(In
Chinese).
|
